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South Africans with recent pregnancy rarely know
partner’s HIV serostatus: implications for
serodiscordant couples interventions
Lynn T Matthews1,2*, Lizzie Moore3, Tamaryn L Crankshaw4, Cecilia Milford3, Fortunate N Mosery3, Ross Greener3,
Christina Psaros5, Steven A Safren5, David R Bangsberg1 and Jennifer A Smit3
Abstract
Background: Implementation of safer conception strategies requires knowledge of partner HIV-serostatus. We
recruited women and men in a high HIV-prevalence setting for a study to assess periconception risk behavior
among individuals reporting HIV-serodiscordant partnerships. We report screening data from that study with the
objective of estimating the proportion of individuals who are aware that they are in an HIV-serodiscordant
relationship at the time of conception.
Methods: We screened women and men attending antenatal and antiretroviral clinics in Durban, South Africa for
enrollment in a study of periconception risk behavior among individuals with serodiscordant partners. Screening
questionnaires assessed for study eligibility including age 18–45 years (for women) or at least 18 years of age
(for men), pregnancy in past year (women) or partner pregnancy in the past 3 years (men), HIV status of partner
for recent pregnancy, participant’s HIV status, and infected partner’s HIV status having been known before the
referent pregnancy.
Results: Among 2620 women screened, 2344 (90%) met age and pregnancy criteria and knew who fathered the
referent pregnancy. Among those women, 963 (41%) did not know the pregnancy partner’s HIV serostatus at time
of screening. Only 92 (4%) reported knowing of a serodiscordant partnership prior to pregnancy. Among 1166 men
screened, 225 (19%) met age and pregnancy criteria. Among those men, 71 (32%) did not know the pregnancy
partner’s HIV status and only 30 (13%) reported knowing of a serodiscordant partnership prior to pregnancy.
Conclusions: In an HIV-endemic setting, awareness of partner HIV serostatus is rare. Innovative strategies to increase
HIV testing and disclosure are required to facilitate HIV prevention interventions for serodiscordant couples.
Keywords: HIV prevention, HIV serodiscordant couples, Safer conception, HIV serostatus disclosure
Background
A large proportion of HIV-infected women and men in
sub-Saharan Africa are in stable serodiscordant sexual re-
lationships [1,2]. As many as 30% of stable heterosexual
couples in South Africa are HIV-1 serodiscordant [3,4].
Because an estimated 50% of HIV transmission occurs be-
tween serodiscordant partners [5], these partnerships rep-
resent a priority population for prevention [6-8].
Among serodiscordant couples, antiretroviral treatment
(ART) for the infected partner reduces sexual transmission
by 96% [7,9,10] and antiretroviral pre-exposure prophy-
laxis (PrEP) for the uninfected partner may reduce sexual
transmission by as much as 75% [11]. The World Health
Organization now recommends that HIV-positive individ-
uals with seronegative partners initiate ART to reduce sex-
ual transmission risk [8,12].
In South Africa, many men and women living with HIV
desire children [13-15]. In the context of highly prevalent
serodiscordance [3,4], high fertility, and an absence of pro-
grams that address periconception transmission [16,17],
HIV incidence in the context of desired pregnancy is likely
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substantial. Antenatal clinic prevalence in KwaZulu-Natal,
South Africa is estimated at 38% [18]. For serodiscordant
couples who want biological children, South African
guidelines recommend early ART for the infected partner
in combination with other safer conception strategies,
such as timed peri-ovulatory intercourse [19]. In order to
implement safer conception strategies, individuals need to
know their HIV status and that of their partner [20].
We recruited women and men in a high HIV-prevalence
setting for a cross-sectional survey to assess periconcep-
tion risk behavior among individuals reporting HIV-
serodiscordant partnerships. Our study sought to enroll
women with recent pregnancy and men with recent part-
ner pregnancy. We report here our screening data with
the objective of estimating the proportion of individuals
who are aware that they are in a serodiscordant relation-
ship at the time of conception.
Methods
The study was completed in a large suburban township
near Durban, South Africa. We recruited participants from
antenatal care (ANC) and antiretroviral (ARV) clinics
within a large hospital which serves a population of up to
two million people.
All women attending ANC were systematically screened
for eligibility by research assistants fluent in English and
isiZulu. We sought to recruit women who were aged 18–
45 and fluent in English or isiZulu; who had been pregnant
in the last 12 months and knew the father’s identity; and
who self-reported either a) known HIV-positive status at
the time of conception with a seronegative or unknown-
status pregnancy partner, or b) HIV-negative status with a
seropositive pregnancy partner whose status was known be-
fore conception.
Women were encouraged to invite their male partners
to participate, but due to limited recruitment, we also
approached men attending the ARV clinic. Men were eli-
gible for enrollment if they were aged 18 or older and
fluent in English or isiZulu; were a partner of an en-
rolled female or reported partner pregnancy in the past
3 years (this longer period was used for men in order to
ensure adequate recruitment); and self-reported either a)
known HIV-positive status at the time of conception with
a seronegative or unknown-status pregnancy partner, or b)
HIV-negative status with a seropositive pregnancy partner
whose status was known before conception. If men re-
ported multiple recent pregnancy partners, we asked them
to refer to the most recent pregnancy; if two or more
pregnancies occurred simultaneously, we asked them to
refer to the pregnancy from the most stable partnership.
Failure to meet any inclusion criterion halted the screen-
ing process. Only enrolled individuals provided identifying
information. All HIV serostatus data were based on self-
report by the index individual in the partnership. These
screening data were collected with verbal consent; this
was a screening procedure which did not collect personal
identifiers.
Study data were collected and managed using REDCap
electronic data capture tools hosted at Partners Health-
Care [21]. All study procedures were approved by The
University of the Witwatersrand Human Research Ethics
Committee (Johannesburg, South Africa), the Partners
(Massachusetts General Hospital) Human Research
Committee (Boston, USA), Provincial and District
Department of Health (eThekwini District, KwaZulu-
Natal), and the local facility.
Results
Between May 2011 and May 2012, 2620 women and
1166 men were screened for eligibility to participate in
the study. Only one man was recruited via partner refer-
ral, the remainder were recruited though the ARV clinic.
Screening results for the women are shown in Figure 1.
Among 2620 women, 90% (n = 2344) met age and preg-
nancy criteria and knew who had fathered the referent
pregnancy. Among those women, 963 (41%) did not know
her pregnancy partner’s current HIV serostatus, 908 (39%)
reported that her partner was currently HIV-negative, and
471 (20%) reported an HIV-positive partner.
Among 963 women who did not know their partner’s
status, 551 (57%) reported her own serostatus as HIV-
positive but only 210 (22%) reported knowing prior to
pregnancy that she was HIV-positive. 387 (40%) reported
HIV-negative serostatus, and 25 (3%) did not know or
refused to state her serostatus.
Among 908 women reporting an HIV-negative partner,
106 (12%) reported her own serostatus as HIV-positive
but only 56 (6%) reported knowing prior to pregnancy
that she was HIV-positive. 799 (88%) reported HIV-
negative serostatus and 3 did not know or refused to
state her serostatus.
Among 471 women reporting an HIV-positive partner,
224 (48%) reported being unaware of this prior to preg-
nancy and thus those women were not asked questions
about their own serostatus (as in methods, failure to meet
any inclusion criterion halted the screening process).
Among the remainder, 208 (44% of all women reporting a
currently HIV-positive partner) reported being HIV-
infected and 36 (8%) reported HIV-negative serostatus.
Thus, only 92 recently pregnant women (4% of women
meeting age and pregnancy criteria) reported being in a
known serodiscordant partnership prior to pregnancy
(depicted by right brackets in Figure 1). An additional
210 (9%) were known HIV-infected prior to pregnancy
with an unknown status partner. Finally, 266 (11%) of
women who met age and pregnancy criteria knew they
were HIV-positive prior to pregnancy with an uninfected
or unknown status partner.
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Screening results for the men are shown in Figure 2.
Among 1166 men screened, the majority (89%) met the
age criterion, but only 225 (22% of those aged 18 and
above) reported partner pregnancy in the past 3 years. We
initially attempted to recruit men with partner pregnancy
in the past year, but had to alter this inclusion criterion
due to low recruitment (either due to low prevalence of
recent partner pregnancy or low reporting thereof). Of
men who met age and pregnancy criteria, 71 (32%) did
not know his partner’s current HIV status, 40 (18%) re-
ported an HIV-negative partner, and 114 (51%) reported
an HIV-positive partner.
Among 71 men reporting an unknown status partner,
68 (96%) reported his own serostatus as HIV-positive
and 61 (86%) reported knowing he was HIV-positive prior
to pregnancy. One reported negative serostatus and 2 did
not know or refused to state his HIV serostatus.
Among 40 men reporting an HIV-negative partner, 35
(88%) reported his own serostatus as HIV-positive and
25 (63%) reported knowing he was HIV-positive prior to
pregnancy. Three reported HIV-negative serostatus and
2 did not know or refused to state his HIV serostatus.
Among 114 men reporting an HIV-positive partner, 71
(62%) did not know her status prior to pregnancy, thus
Figure 1 Partner and personal HIV serostatus by self-report among 2344 women with recent pregnancy. Legend: The 3 main bars show
the proportion of women reporting recent pregnancy partners of unknown, HIV-negative, and HIV-positive serostatus. Within the bars, the shaded
sections represent the proportion of women reporting specific HIV serostatus within those partnerships. Women in known serodiscordant
relationships prior to pregnancy represent just 4% of the 2344 women screened: this group is indicated by right brackets.
Figure 2 Partner and personal HIV serostatus by self-report among 225 men with recent partner pregnancy. Legend: The 3 main bars
show the proportion of men reporting recent pregnancy partners of unknown, HIV-negative, and HIV-positive serostatus. Within the bars, the
shaded sections represent the proportion of men reporting specific HIV serostatus within those partnerships. Men in known serodiscordant
relationships prior to pregnancy represent just 13% of the 225 men screened: this group is indicated by right brackets.
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those men were not asked questions about their own
serostatus. Among the remainder, 38 (33% of all men
reporting a currently HIV-positive partner) reported being
HIV-infected and 5 (4%) reported HIV-negative serostatus.
Thus, a total of 30 men with recent partner pregnancy
(13% of men meeting age and pregnancy criteria) reported
being in a known serodiscordant partnership prior to
pregnancy (depicted by right brackets in Figure 2) and an
additional 61 (27%) were known HIV-infected prior to
pregnancy with an unknown status partner. Finally, 86
(38%) of men who met age and pregnancy criteria, knew
they were HIV-positive prior to a pregnancy with an unin-
fected or uknown-serostatus partner.
Discussion
In an HIV-endemic setting, a large proportion of women
(41%) and men (32%) with recent (partner) pregnancy
did not know their partner’s HIV serostatus. Just 4% of
2344 women and 13% of 255 men who met age and
pregnancy criteria knew that they were in a serodiscor-
dant relationship prior to pregnancy. HIV prevalence for
adults aged 15–49 years in KwaZulu-Natal is estimated
at 28% [22] and the prevalence of serodiscordant couples
is likely between 20 and 30% [3,4]. Thus, our data are
unlikely to reflect low prevalence of serodiscordant cou-
ples, rather they indicate the low prevalence of HIV seros-
tatus disclosure and/or knowledge of personal HIV status.
HIV prevention strategies targeting HIV-serodiscordant
couples, such as early ART or PrEP, may have limited im-
pact in South Africa without innovative solutions to in-
crease testing and mutual disclosure between sexual
partners.
Disclosure is a complex process affected by fear of
stigma and discrimination [23-25], level of engagement
with HIV care [26,27], concepts of masculinity [28],
communication within the relationship [29], and preg-
nancy itself [23,28,30]. Although mutual disclosure can
facilitate informed decision-making and safer sex prac-
tices [26,27], non-disclosure to sexual partners is com-
mon in South Africa [24,26,27,31]. Moreover, knowledge
of HIV serostatus – a first step towards serostatus dis-
closure – remains inadequate, especially among men
[22,32]. In our sample, 29% of HIV-positive men and
47% of HIV-positive women reporting HIV-negative
partners were unaware of their own status prior to the
referent pregnancy. Evidence suggests that stigma and
negative attitudes towards HIV counseling and testing
(HCT), as well as the physical spaces in which this is of-
fered, continue to influence poor uptake [33-35].
To address this problem, current national [36,37] and
international [8] guidelines advocate couples-based HIV
counseling and testing (CHCT). This has been associ-
ated with increased disclosure to sexual partners, en-
hanced adherence to interventions to reduce perinatal
HIV transmission, and reductions in sexual risk behavior
[38]. Yet little published data exists on CHCT in South
Africa [24,30,39]. In a Western Cape study to promote
CHCT in an ANC setting, 35% of men whose pregnant
partners were given invitations for them to attend com-
pleted HCT, versus 11% of men whose partners received
pregnancy education alone [40]. A behavioral intervention
for pregnant women and their partners in Mpumalanga
(Partnersplus) resulted in a small increase in male HIV
testing and disclosure [41]. Anecdotal evidence suggests
that some South African men and women use CHCT as a
means of disclosure [34,39]; however, access to and uptake
of CHCT services nationally is undetermined.
Further research into CHCT is of great importance in
South Africa. However, limited recruitment for couples-
based interventions may forecast challenges to more wide-
spread implementation of CHCT in South Africa: 40% of
screened pregnant women could not recruit partners to
the Partnersplus project [41], (D. Jones, personal commu-
nication, May 2013) and the Project Accept team screened
more than three times the number of index individuals in
order to interview 20 couples [42]. In our study, among
248 enrolled women, only one recruited her male partner.
A ‘couple-oriented’ approach to HCT [43], which includes
counseling on strategies for disclosure and to encourage
partner HCT, may therefore be an important alternative in
this context. This approach has demonstrated success in a
recent multisite study (including one site in sub-Saharan
Africa) but awaits further exploration in South Africa [43].
Although HIV prevention interventions for pregnant
couples target perinatal rather than periconception trans-
mission, their relative successes demonstrate that the de-
sire for a healthy child can act as a powerful lever for HIV
prevention. Incorporating messages on testing and mutual
disclosure into PMTCT education may reduce pericon-
ception HIV transmission by moving the HIV prevention
time frame ‘for a healthy baby’ up to pre-conception.
Our data suggest a high level of periconception HIV risk
behavior among known HIV-positive individuals: of par-
ticipants who met age and pregnancy criteria, 38% of men
and 11% of women knew they were HIV-positive prior to
pregnancy with an at-risk partner (pooled results for those
reporting HIV-negative or unknown serostatus partners).
While we do not dispute the right of these individuals
to have children, many of these pregnancies were likely
unintended [44-47]. There is a clear need for safer con-
ception programs for those who choose to conceive
and improved access to contraception for those who
do not want to conceive [20].
These screening data represent a large sample of women
and men in an HIV-endemic area with recent pregnancy.
Limitations to interpretation include social desirability
bias: men and women who knew their HIV status prior to
pregnancy may have been reluctant to report this given
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counseling messages that persons living with HIV should
not have sex without condoms; individuals may also have
been reluctant to report partner serostatus. In addition,
serodiscordance status is based on the report from just
one partner. While most women were pregnant at time of
screening, men were asked to reflect on a partner preg-
nancy in the past three years, thus recall bias may have af-
fected responses. Additionally, since limited partner
recruitment required us to enroll men from ARV clinic,
male and female participants likely had very different ex-
periences of HIV, with men more likely than women to be
HIV-infected, and if so, to be engaged with treatment and
support. Our screening tool stopped when any inclusion
criterion was not met, thus the data are incomplete for the
full sample of screened individuals.
Conclusions
In an HIV-endemic setting, a large proportion of women
(41%) and men (32%) did not know their recent pregnancy
partner’s HIV serostatus. Safer conception and general
HIV prevention strategies for HIV-serodiscordant couples
require innovative solutions to increase testing and mutual
disclosure between sexual partners. In addition, a harm-
reduction approach to reducing periconception transmis-
sion should address couples as well as individuals who
cannot engage their partners.
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